Daratumumab/rHuPH20 clinical trials

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

This study looks at different treatment plans for multiple myeloma after a stem cell transplant. It compares a drug called Lenalidomide with a combination of Lenalidomide and Daratumumab, to see which works best and for how long, based on how well the myeloma responds.